Eupraxia Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference Life Science Investing
Mindset Pharma Files National Patents Protecting Family 1 Application in 16 Different Countries Life Science Investing
Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research Pharmaceutical Investing
Bristol Myers Squibb to Report Results for Third Quarter 2022 on October 26, 2022 Pharmaceutical Investing
Kite's CAR T-cell Therapy Tecartus® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia Pharmaceutical Investing
Vegan Supply to Distribute Plantein Through Foodservice Network & Sell in Retail Store Life Science Investing
The Gummy Project Announces Commencement of Second Production Run of Peachy Bees and Watermelon Sharks in Preparation for Strategic Expansion into the United States Life Science Investing
Business Intelligence Group Awards BioHarvest Sciences with the Prestigious Sustainability Leadership Award Company News
Bristol Myers Squibb to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Pharmaceutical Investing
Bristol Myers Squibb Research at ESMO Congress 2022 Highlights Depth of Development Program Across Early- and Late-Stages of Cancer Pharmaceutical Investing
New TROPiCS-02 Data in HR+/HER2- Metastatic Breast Cancer Patients Demonstrates Progression-Free Survival Benefit of Trodelvy® Regardless of Their HER2 Status Pharmaceutical Investing
